Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05044104 Not yet recruiting - Healthy Clinical Trials

Wearable Technology in Endoscopy

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Researchers are assessing the accuracy and safety of wearable technology in subjects undergoing endoscopic gastrointestinal procedures with sedation.

NCT ID: NCT05043792 Recruiting - Healthy Clinical Trials

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi Ascending Dose of TT-00920 in Healthy Subjects

Start date: September 1, 2021
Phase: Phase 1
Study type: Interventional

This is a double-blind, randomized, placebo-controlled, multiple ascending dose escalation study of TT-00920 in healthy subjects.

NCT ID: NCT05042310 Not yet recruiting - Healthy Clinical Trials

A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants

Start date: October 4, 2021
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the safety and tolerability of LY3541860 in healthy Japanese and non-Japanese participants. The study will also assess how fast LY3541860 gets into the blood stream and how long it takes the body to remove it. The study is open to healthy participants. The study will last up to approximately 113 days.

NCT ID: NCT05041595 Enrolling by invitation - Healthy Clinical Trials

Lyme Disease Diagnostic Assay - Collection of Whole Blood

Start date: May 3, 2021
Phase:
Study type: Observational

The primary objective is to obtain whole blood from subjects with an established diagnosis of early Borrelisois expressing with EM rash. Whole blood will also be obtained from subjects without EM rash but with signs and symptoms consistent with suspicion of acute Borreliosis and under medical examination for Lyme disease. In addition, whole blood will be obtained from apparently healthy subjects residing in areas endemic to Lyme disease and apparently healthy subjects residing in areas non-endemic to Lyme disease.

NCT ID: NCT05041192 Enrolling by invitation - Healthy Clinical Trials

The Effects of Synaquell on Brain Function

Start date: September 3, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the dietary supplement, Synaquell (TM), for effects on brain function.

NCT ID: NCT05040204 Not yet recruiting - Healthy Clinical Trials

The Effects of Dietary Supplementation on Serum Protein Glycosylation

Start date: October 2021
Phase: Phase 1
Study type: Interventional

Two randomized double-blind placebo-controlled clinical studies to assess the effects of dietary glycan monomer supplementation on the immune system, especially antibody glycosylation in healthy adults. Immune profiling and glycoproteomics will be performed on serum isolated at these same time points.

NCT ID: NCT05038969 Completed - Healthy Clinical Trials

Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries, Egypt) and Nexium 40 mg Delayed Release Capsules (AstraZeneca Sweden, Product of France)

Start date: March 18, 2021
Phase: Phase 1
Study type: Interventional

Comparative randomized, single dose Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries, Egypt) and Nexium 40 mg Delayed Release Capsules (AstraZeneca Sweden, Product of France) in Healthy Human Volunteers Under Fasting Condition.

NCT ID: NCT05038787 Not yet recruiting - Healthy Clinical Trials

A Study of LY3473329 in Healthy Japanese Participants

Start date: September 28, 2021
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the safety and tolerability of LY3473329 in healthy Japanese participants. The study will also assess how fast LY3473329 gets into the blood stream and how long it takes the body to remove it. The study is open to healthy participants. The study will last up to about 71 days, inclusive of screening period.

NCT ID: NCT05037864 Not yet recruiting - Healthy Clinical Trials

A Comparison of Posture, Balance and Flexibility in Between Adolescent Ballet Dancers and Sedentary Individuals

Start date: September 2, 2021
Phase:
Study type: Observational

Ballet dance is as a superlative combination of art and sport that requires high demands musculoskeletal conditioning which works on the development of coordination, balance and associated with efficient strength and flexibility. Ballet dance are typical specific movement which require balance ability and postural control. Ballet dancers use specific balance exercises. It can be expected, that dancers have an advanced sense of awareness for the placement and motion of their bodies. The support surfaces are variable in ballet training, this may also be the reason dancers can better use the information from the somatosensory and vestibular systems. It could be assumed that the effect of ballet training will have a positive effect on postural stability in standing. It is still unclear whether balance, flexibility and posture in adolescent ballet dancers is different than sedentary adolescent. Therefore, the aim of this study was to assess whether there are differences in balance between adolescent ballet dancers and sedentary adolescent and if these differences are associated with the flexibility and posture. To compare the postural balance between both groups the unipedal standing was chosen, which reduces the quantity of useful and accurate somatosensory information available to the postural control system. Posture analysis and flexibility tests were performed in both groups to compare flexibility and posture on balance. We purpose to compare balance parameters, posture and health quality parameters in adolescent ballet dancers and sedentary adolescent groups.

NCT ID: NCT05037409 Not yet recruiting - Healthy Clinical Trials

Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy Participants

Start date: October 2, 2021
Phase: Phase 1
Study type: Interventional

Purpose of the study is to evaluate the safety, tolerability, immunogenicity and pharmacokinetics (PK) of PF-06823859 following a single intravenous dose of PF-06823859 300 and 900 mg in Japanese healthy adult participants.